Beth Bioinformatics Co., Limited

Beth Bioinformatics (BethBio) is a biotech company that develops state-of-the-art technologies to empower the development of new and better vaccines. Utilizing virology, AI and computational biology, BethBio provides a series of innovative bioinformatics solutions to pharmaceutical companies, including virus evolution prediction for SARS-CoV-2 and Influenza, antigen design, real-time vaccine effectiveness (VE) evaluation, clinical trial design, codon optimization / deoptimization and more. These solutions could help our clients solve various technical difficulties, increase VE or manufacture efficiency of their vaccines, and improve chances of obtaining regulatory approval. The company is working closely with pharmaceutical companies, including several new vaccine co-development projects.

Utilizing virology, AI and computational biology, BethBio provides a series of innovative bioinformatics solutions to pharmaceutical companies, including virus evolution prediction for SARS-CoV-2 and Influenza, antigen design, real-time vaccine effectiveness (VE) evaluation, clinical trial design, codon optimization / deoptimization and more. BethBio co-develops new vaccine candidates with pharmaceutical companies, while also accepts consultation projects, service contracts, licensing requests and research commissions.